Pfizer Inc (PFE) - Specialty Revenue (DISCONTINUED) (I:PIPFESR)
13.83B USD for 2022
Level Chart
Basic Info
|
Pfizer Inc (PFE) - Specialty Revenue is at a current level of 13.83B, down from 15.19B one year ago. This is a change of -8.96% from one year ago. |
|
Specialty Revenue refers to the revenue generated from the sales of specialized or niche medications and treatments that are used to address specific medical conditions. |
| Report | FinChat.io |
| Category | Segments & KPIs |
| Region | United States |
| Source | FinChat.io |
|
Data provided via FinChat.io |
Stats
| Last Value | 13.83B |
| Latest Period | 2022 |
| Last Updated | Oct 5 2023, 11:15 EDT |
| Average Growth Rate | -8.96% |
| Value from 1 Year Ago | 15.19B |
| Change from 1 Year Ago | -8.96% |
| Frequency | Yearly |
| Unit | USD |
| Adjustment | N/A |
Historical Data
| Date | Value |
|---|---|
| December 31, 2022 | 13.83B |
| December 31, 2021 | 15.19B |
| December 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
News
Headline
Wire
Time (ET)
Accesswire
11/15 12:05
PR Newswire
11/12 08:00
PR Newswire
11/05 05:00
PR Newswire
10/31 07:30
PR Newswire
10/30 06:30
PR Newswire
10/30 06:11
Basic Info
|
Pfizer Inc (PFE) - Specialty Revenue is at a current level of 13.83B, down from 15.19B one year ago. This is a change of -8.96% from one year ago. |
|
Specialty Revenue refers to the revenue generated from the sales of specialized or niche medications and treatments that are used to address specific medical conditions. |
| Report | FinChat.io |
| Category | Segments & KPIs |
| Region | United States |
| Source | FinChat.io |
|
Data provided via FinChat.io |
Stats
| Last Value | 13.83B |
| Latest Period | 2022 |
| Last Updated | Oct 5 2023, 11:15 EDT |
| Average Growth Rate | -8.96% |
| Value from 1 Year Ago | 15.19B |
| Change from 1 Year Ago | -8.96% |
| Frequency | Yearly |
| Unit | USD |
| Adjustment | N/A |